Blue Sail Financials
| 002382 Stock | 4.85 0.01 0.21% |
Blue | Select Account or Indicator |
Understanding current and past Blue Sail Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Blue Sail's financial statements are interrelated, with each one affecting the others. For example, an increase in Blue Sail's assets may result in an increase in income on the income statement.
Please note, the presentation of Blue Sail's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Blue Sail's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Blue Sail's management manipulating its earnings.
Blue Sail Stock Summary
Blue Sail competes with Beijing Bewinner, Jilin Jlu, Nanjing Putian, China Mobile, and Beijing Kingsoft. Blue Sail is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100000MZ7 |
| Business Address | 48 Yinuo Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.bluesail.cn |
| Phone | 86 53 3787 1008 |
You should never invest in Blue Sail without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Blue Stock, because this is throwing your money away. Analyzing the key information contained in Blue Sail's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Blue Sail Key Financial Ratios
Blue Sail's financial ratios allow both analysts and investors to convert raw data from Blue Sail's financial statements into concise, actionable information that can be used to evaluate the performance of Blue Sail over time and compare it to other companies across industries.| Revenue | 4.93 B | ||||
| Gross Profit | 857.27 M | ||||
| EBITDA | 198.28 M | ||||
| Net Income | (568.36 M) | ||||
| Total Asset | 15.63 B |
Blue Sail Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 17.0B | 16.9B | 15.9B | 15.6B | 18.0B | 18.9B | |
| Other Current Liab | 9.5M | 2.4M | 1.6B | 1.2M | 1.4M | 1.3M | |
| Net Debt | 1.7B | 891.3M | 1.2B | 2.6B | 3.0B | 3.1B | |
| Retained Earnings | 2.8B | 3.5B | 3.1B | 2.1B | 2.4B | 2.6B | |
| Accounts Payable | 785.3M | 464.5M | 266.8M | 431.0M | 495.7M | 320.6M | |
| Cash | 3.8B | 2.8B | 2.0B | 1.3B | 1.5B | 1.0B | |
| Net Receivables | 1.3B | 908.3M | 906.9M | 897.3M | 1.0B | 1.1B | |
| Inventory | 768.8M | 1.1B | 916.8M | 1.1B | 1.2B | 1.3B | |
| Other Current Assets | 295.6M | 823.3M | 73.7M | 107.1M | 123.2M | 101.1M | |
| Total Liab | 7.2B | 6.4B | 5.3B | 6.1B | 7.0B | 7.3B | |
| Total Current Assets | 7.2B | 6.3B | 4.4B | 3.8B | 4.3B | 2.2B | |
| Short Term Debt | 2.2B | 802.8M | 368.7M | 2.0B | 2.3B | 2.5B | |
| Common Stock | 980.9M | 1.0B | 1.0B | 1.0B | 1.2B | 1.2B | |
| Intangible Assets | 1.2B | 959.7M | 1.2B | 1.3B | 1.4B | 1.5B | |
| Other Liab | 193.3M | 178.8M | 265.0M | 199.8M | 229.8M | 241.3M | |
| Long Term Debt | 3.4B | 2.9B | 2.8B | 1.8B | 2.1B | 2.1B | |
| Good Will | 5.4B | 3.5B | 3.8B | 3.9B | 4.5B | 2.5B | |
| Net Tangible Assets | 1.0B | 3.5B | 6.1B | 5.7B | 6.5B | 6.8B | |
| Net Invested Capital | 13.5B | 13.4B | 13.5B | 11.9B | 13.7B | 11.9B | |
| Short Long Term Debt | 310.0M | 12.6M | 153.5M | 543.1M | 624.5M | 318.4M | |
| Net Working Capital | 3.5B | 3.2B | 2.1B | (139.1M) | (160.0M) | (152.0M) | |
| Capital Stock | 980.9M | 1.0B | 1.0B | 1.0B | 1.2B | 1.1B |
Blue Sail Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 189.9M | 133.3M | 129.5M | 180.5M | 207.5M | 217.9M | |
| Total Revenue | 7.9B | 8.1B | 4.9B | 4.9B | 5.7B | 5.9B | |
| Operating Income | 4.1B | 2.6B | (526.7M) | (470.0M) | (540.5M) | (513.5M) | |
| Cost Of Revenue | 2.8B | 4.3B | 4.4B | 4.3B | 5.0B | 5.2B | |
| Income Before Tax | 2.0B | 1.3B | (405.9M) | (622.6M) | (716.0M) | (680.2M) | |
| Net Income | 1.8B | 1.2B | (372.3M) | (568.4M) | (653.6M) | (620.9M) | |
| Income Tax Expense | 56.8M | 255.3M | 191.6M | (33.5M) | (38.6M) | (36.6M) | |
| Research Development | 291.4M | 438.5M | 352.5M | 290.8M | 334.4M | 201.7M | |
| Tax Provision | 255.3M | 191.6M | (33.5M) | (54.2M) | (48.8M) | (46.4M) | |
| Net Interest Income | (280.1M) | (81.1M) | (96.7M) | (158.1M) | (142.3M) | (149.4M) | |
| Interest Income | 64.0M | 56.7M | 36.7M | 26.3M | 30.2M | 35.1M | |
| Gross Profit | 5.1B | 3.8B | 501.5M | 606.1M | 697.0M | 662.1M | |
| Ebit | 625.4M | 4.0B | 2.4B | (674.0M) | (775.1M) | (736.4M) | |
| Minority Interest | 31.2M | 114.9K | 554.99 | 15.66 | 14.09 | 13.39 | |
| Ebitda | 876.3M | 2.4B | 1.8B | 212.6M | 244.5M | 232.3M |
Blue Sail Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Blue Sail Medical. It measures of how well Blue is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Blue Sail brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Blue had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Blue Sail has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Dividends Paid | 282.1M | 477.2M | 61.0M | 513.8M | 590.8M | 620.4M | |
| Capital Expenditures | 1.2B | 2.6B | 896.9M | 774.1M | 890.3M | 508.0M | |
| Net Income | 1.8B | 1.2B | (372.3M) | (568.4M) | (653.6M) | (620.9M) | |
| Change To Inventory | (342.9M) | (426.5M) | 176.5M | (146.3M) | (131.7M) | (125.1M) | |
| Investments | (1.7B) | 33.1M | 1.0B | (870.7M) | (783.7M) | (744.5M) | |
| Change In Cash | 2.0B | (1.2B) | (42.8M) | (789.8M) | (710.8M) | (675.2M) | |
| Net Borrowings | (44.5M) | 1.9B | (506.3M) | (650.7M) | (585.6M) | (556.3M) | |
| Depreciation | 213.7M | 332.2M | 482.7M | 524.5M | 603.2M | 633.3M | |
| End Period Cash Flow | 3.1B | 1.9B | 1.9B | 1.1B | 1.2B | 1.4B | |
| Change To Netincome | 117.6M | 2.0B | 1.2B | (81.7M) | (93.9M) | (89.2M) | |
| Free Cash Flow | 2.5B | (336.2M) | (402.4M) | (847.0M) | (762.3M) | (724.2M) | |
| Other Non Cash Items | 206.0M | 119.8M | 121.3M | 210.8M | 242.4M | 130.8M |
Blue Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Blue Sail's current stock value. Our valuation model uses many indicators to compare Blue Sail value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Blue Sail competition to find correlations between indicators driving Blue Sail's intrinsic value. More Info.Blue Sail Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Blue Sail by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Blue Sail's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Blue Sail Medical Systematic Risk
Blue Sail's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Blue Sail volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Blue Sail Medical correlated with the market. If Beta is less than 0 Blue Sail generally moves in the opposite direction as compared to the market. If Blue Sail Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Blue Sail Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Blue Sail is generally in the same direction as the market. If Beta > 1 Blue Sail moves generally in the same direction as, but more than the movement of the benchmark.
Blue Sail Medical Total Assets Over Time
Blue Sail Thematic Clasifications
Blue Sail Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Blue Sail January 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Blue Sail help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Blue Sail Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Blue Sail Medical based on widely used predictive technical indicators. In general, we focus on analyzing Blue Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Blue Sail's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 8.33 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 3.16 |
Complementary Tools for Blue Stock analysis
When running Blue Sail's price analysis, check to measure Blue Sail's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blue Sail is operating at the current time. Most of Blue Sail's value examination focuses on studying past and present price action to predict the probability of Blue Sail's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blue Sail's price. Additionally, you may evaluate how the addition of Blue Sail to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |